- published: 23 Jan 2015
- views: 228
Create your page here
Monday, 12 September 2016
-
remove the playlistBioprocess International 2014 Interview John Cox, Biogen Idec
-
remove the playlistLongest Videos
- remove the playlistBioprocess International 2014 Interview John Cox, Biogen Idec
- remove the playlistLongest Videos
back to playlist
In this interview, John Cox of Biogen Idec discusses the changes in bioprocessing over the past twenty years, what technologies are going to come into play, the trend towards disposable technologies, the challenges of throughput, continuous processing and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
In this interview, Jonathan Romero of Biogen Idec looks at the lifecycle management of product development, the changing environment of biopharmceutical product demands and matching those to their facilities infrastructures, innovation versus regulated processes to produce biopharmaceuticals, and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 114
An interview with Sumit Goswami, Ph.D., Senior Scientist, Biotherapeutics, Pharmaceutical R&D; at Pfizer, from IBC Life Sciences' 2014 BioProcess International Conference & Exhibition in Boston, MA. At the conference, Dr. Goswami presented a case study on "Measurement of Charge: An Important Molecular Property for Predicting High Concentration Behavior."
- published: 12 Jun 2015
- views: 127
In this interview, Guenter Jagschies discusses manufacturing facilities, how to access facilities where your biologics can be produced, adjusting facilities to be efficient years after they are built, and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 93
In this interview, Ralph Lambalot of Abbvie looks at the drivers and barriers to innovation in the bioprocessing industry. He sees disruptions in the industry coming in the form of biosimilars, molecule characterization, and changes within manufacturing technologies and how disposable manufacturing is changing their approach to developing molecules.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 121
In this interview with David Kolwick, he looks at the future of supply chains for bioprocessing, data collaboration possibilities for suppliers, globalization of the pharmaceutical supply chain and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 41
In this interview, Bob Mattaliano discusses patient experiences and how pressure of the healthcare system influences drug development. He emphasizes the patient experience. He also discusses the challenge of attracting and keeping the great minds of biopharma.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 85
This September Biogen Idec held it's 4th Annual Care Deeply Day, where employees volunteer across the globe in their local communities.
The Biogen Idec Care Deeply Volunteer Day is part of the company’s philanthropic focus on patients, science education and supporting local community needs.
This was our largest Care Deeply Day ever with over 2900 employees participating in over 140 Projects, volunteering over 14,500 hours in 27 countries. #CareDeeplyDay
- published: 03 Oct 2014
- views: 1665
Global biotechnology firm Biogen Idec Inc. (NASDAQ:BIIB) announced management changes Tuesday morning, including the retirement of its president, CEO and director, James C. Mullen, who will retire from his position on June 8th.
The company's board of directors said they are in the final stages of picking a new CEO and will announce the new team member in the weeks ahead.
During the interim period, Biogen Idec's senior leadership will report to chairman of the board William D. Young.
"The Board has conducted a thorough selection process and is unified in its view that we will have the right leader with the right experience in place very soon to take Biogen Idec to the next level," said Young. "We expect to announce the appointment shortly."
Chief operating officer Robert A. Hamm will also retire on December 31st of this year, after 16 years with the company.
John G. Cox has been promoted to executive vice president of pharmaceutical operations and technology, and will oversee global manufacturing, technical development, supply chain, and more, for the company.
"On behalf of the board, I would like to reiterate our deepest thanks to Jim Mullen and Bob Hamm for their many years of leadership and contributions to the growth of Biogen Idec into a global biotechnology leader," said Young. "We wish them well in the future. We are pleased that John Cox has joined our talented senior leadership team."
Shares of Biogen Idec are trading down 0.92% Tuesday morning at $47.20.
- published: 08 Jun 2010
- views: 1040
- Loading...
-
4:53BioProcess International 2014 Interview: John Cox, Biogen Idec
BioProcess International 2014 Interview: John Cox, Biogen IdecBioProcess International 2014 Interview: John Cox, Biogen Idec
In this interview, John Cox of Biogen Idec discusses the changes in bioprocessing over the past twenty years, what technologies are going to come into play, the trend towards disposable technologies, the challenges of throughput, continuous processing and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
5:43BioProcess International 2014 Interview: Jonathan Romero, Biogen Idec
BioProcess International 2014 Interview: Jonathan Romero, Biogen IdecBioProcess International 2014 Interview: Jonathan Romero, Biogen Idec
In this interview, Jonathan Romero of Biogen Idec looks at the lifecycle management of product development, the changing environment of biopharmceutical product demands and matching those to their facilities infrastructures, innovation versus regulated processes to produce biopharmaceuticals, and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
6:49BioProcess International 2014 Interview: Sumit Goswami, Pfizer
BioProcess International 2014 Interview: Sumit Goswami, PfizerBioProcess International 2014 Interview: Sumit Goswami, Pfizer
An interview with Sumit Goswami, Ph.D., Senior Scientist, Biotherapeutics, Pharmaceutical R&D; at Pfizer, from IBC Life Sciences' 2014 BioProcess International Conference & Exhibition in Boston, MA. At the conference, Dr. Goswami presented a case study on "Measurement of Charge: An Important Molecular Property for Predicting High Concentration Behavior." -
7:56BioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life Sciences
BioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life SciencesBioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life Sciences
In this interview, Guenter Jagschies discusses manufacturing facilities, how to access facilities where your biologics can be produced, adjusting facilities to be efficient years after they are built, and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
5:38BioProcess International 2014 Interview: Ralph Lambalot, Abbvie
BioProcess International 2014 Interview: Ralph Lambalot, AbbvieBioProcess International 2014 Interview: Ralph Lambalot, Abbvie
In this interview, Ralph Lambalot of Abbvie looks at the drivers and barriers to innovation in the bioprocessing industry. He sees disruptions in the industry coming in the form of biosimilars, molecule characterization, and changes within manufacturing technologies and how disposable manufacturing is changing their approach to developing molecules. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
5:31BioProcess International 2014 Interview: David Kolwick, Amgen
BioProcess International 2014 Interview: David Kolwick, AmgenBioProcess International 2014 Interview: David Kolwick, Amgen
In this interview with David Kolwick, he looks at the future of supply chains for bioprocessing, data collaboration possibilities for suppliers, globalization of the pharmaceutical supply chain and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
3:59BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; Center
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; CenterBioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; Center
In this interview, Bob Mattaliano discusses patient experiences and how pressure of the healthcare system influences drug development. He emphasizes the patient experience. He also discusses the challenge of attracting and keeping the great minds of biopharma. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
2:34Biogen Idec Care Deeply Day 2014
Biogen Idec Care Deeply Day 2014Biogen Idec Care Deeply Day 2014
This September Biogen Idec held it's 4th Annual Care Deeply Day, where employees volunteer across the globe in their local communities. The Biogen Idec Care Deeply Volunteer Day is part of the company’s philanthropic focus on patients, science education and supporting local community needs. This was our largest Care Deeply Day ever with over 2900 employees participating in over 140 Projects, volunteering over 14,500 hours in 27 countries. #CareDeeplyDay -
10:48SaharaTV interview with John Cox on September 8th, 2012.
SaharaTV interview with John Cox on September 8th, 2012.SaharaTV interview with John Cox on September 8th, 2012.
-
1:48News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)
News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)
Global biotechnology firm Biogen Idec Inc. (NASDAQ:BIIB) announced management changes Tuesday morning, including the retirement of its president, CEO and director, James C. Mullen, who will retire from his position on June 8th. The company's board of directors said they are in the final stages of picking a new CEO and will announce the new team member in the weeks ahead. During the interim period, Biogen Idec's senior leadership will report to chairman of the board William D. Young. "The Board has conducted a thorough selection process and is unified in its view that we will have the right leader with the right experience in place very soon to take Biogen Idec to the next level," said Young. "We expect to announce the appointment shortly." Chief operating officer Robert A. Hamm will also retire on December 31st of this year, after 16 years with the company. John G. Cox has been promoted to executive vice president of pharmaceutical operations and technology, and will oversee global manufacturing, technical development, supply chain, and more, for the company. "On behalf of the board, I would like to reiterate our deepest thanks to Jim Mullen and Bob Hamm for their many years of leadership and contributions to the growth of Biogen Idec into a global biotechnology leader," said Young. "We wish them well in the future. We are pleased that John Cox has joined our talented senior leadership team." Shares of Biogen Idec are trading down 0.92% Tuesday morning at $47.20.
-
BioProcess International 2014 Interview: John Cox, Biogen Idec
In this interview, John Cox of Biogen Idec discusses the changes in bioprocessing over the past twenty years, what technologies are going to come into play, the trend towards disposable technologies, the challenges of throughput, continuous processing and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
BioProcess International 2014 Interview: Jonathan Romero, Biogen Idec
In this interview, Jonathan Romero of Biogen Idec looks at the lifecycle management of product development, the changing environment of biopharmceutical product demands and matching those to their facilities infrastructures, innovation versus regulated processes to produce biopharmaceuticals, and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
BioProcess International 2014 Interview: Sumit Goswami, Pfizer
An interview with Sumit Goswami, Ph.D., Senior Scientist, Biotherapeutics, Pharmaceutical R&D; at Pfizer, from IBC Life Sciences' 2014 BioProcess International Conference & Exhibition in Boston, MA. At the conference, Dr. Goswami presented a case study on "Measurement of Charge: An Important Molecular Property for Predicting High Concentration Behavior." -
BioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life Sciences
In this interview, Guenter Jagschies discusses manufacturing facilities, how to access facilities where your biologics can be produced, adjusting facilities to be efficient years after they are built, and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
BioProcess International 2014 Interview: Ralph Lambalot, Abbvie
In this interview, Ralph Lambalot of Abbvie looks at the drivers and barriers to innovation in the bioprocessing industry. He sees disruptions in the industry coming in the form of biosimilars, molecule characterization, and changes within manufacturing technologies and how disposable manufacturing is changing their approach to developing molecules. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
BioProcess International 2014 Interview: David Kolwick, Amgen
In this interview with David Kolwick, he looks at the future of supply chains for bioprocessing, data collaboration possibilities for suppliers, globalization of the pharmaceutical supply chain and more. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; Center
In this interview, Bob Mattaliano discusses patient experiences and how pressure of the healthcare system influences drug development. He emphasizes the patient experience. He also discusses the challenge of attracting and keeping the great minds of biopharma. For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe -
Biogen Idec Care Deeply Day 2014
This September Biogen Idec held it's 4th Annual Care Deeply Day, where employees volunteer across the globe in their local communities. The Biogen Idec Care Deeply Volunteer Day is part of the company’s philanthropic focus on patients, science education and supporting local community needs. This was our largest Care Deeply Day ever with over 2900 employees participating in over 140 Projects, volunteering over 14,500 hours in 27 countries. #CareDeeplyDay -
SaharaTV interview with John Cox on September 8th, 2012.
-
News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)
Global biotechnology firm Biogen Idec Inc. (NASDAQ:BIIB) announced management changes Tuesday morning, including the retirement of its president, CEO and director, James C. Mullen, who will retire from his position on June 8th. The company's board of directors said they are in the final stages of picking a new CEO and will announce the new team member in the weeks ahead. During the interim period, Biogen Idec's senior leadership will report to chairman of the board William D. Young. "The Board has conducted a thorough selection process and is unified in its view that we will have the right leader with the right experience in place very soon to take Biogen Idec to the next level," said Young. "We expect to announce the appointment shortly." Chief operating officer Robert A. Hamm will al...
BioProcess International 2014 Interview: John Cox, Biogen Idec
- Order: Reorder
- Duration: 4:53
- Updated: 23 Jan 2015
- views: 228
In this interview, John Cox of Biogen Idec discusses the changes in bioprocessing over the past twenty years, what technologies are going to come into play, the...
In this interview, John Cox of Biogen Idec discusses the changes in bioprocessing over the past twenty years, what technologies are going to come into play, the trend towards disposable technologies, the challenges of throughput, continuous processing and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
wn.com/Bioprocess International 2014 Interview John Cox, Biogen Idec
In this interview, John Cox of Biogen Idec discusses the changes in bioprocessing over the past twenty years, what technologies are going to come into play, the trend towards disposable technologies, the challenges of throughput, continuous processing and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 228
BioProcess International 2014 Interview: Jonathan Romero, Biogen Idec
- Order: Reorder
- Duration: 5:43
- Updated: 23 Jan 2015
- views: 114
In this interview, Jonathan Romero of Biogen Idec looks at the lifecycle management of product development, the changing environment of biopharmceutical product...
In this interview, Jonathan Romero of Biogen Idec looks at the lifecycle management of product development, the changing environment of biopharmceutical product demands and matching those to their facilities infrastructures, innovation versus regulated processes to produce biopharmaceuticals, and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
wn.com/Bioprocess International 2014 Interview Jonathan Romero, Biogen Idec
In this interview, Jonathan Romero of Biogen Idec looks at the lifecycle management of product development, the changing environment of biopharmceutical product demands and matching those to their facilities infrastructures, innovation versus regulated processes to produce biopharmaceuticals, and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 114
BioProcess International 2014 Interview: Sumit Goswami, Pfizer
- Order: Reorder
- Duration: 6:49
- Updated: 12 Jun 2015
- views: 127
An interview with Sumit Goswami, Ph.D., Senior Scientist, Biotherapeutics, Pharmaceutical R&D; at Pfizer, from IBC Life Sciences' 2014 BioProcess International C...
An interview with Sumit Goswami, Ph.D., Senior Scientist, Biotherapeutics, Pharmaceutical R&D; at Pfizer, from IBC Life Sciences' 2014 BioProcess International Conference & Exhibition in Boston, MA. At the conference, Dr. Goswami presented a case study on "Measurement of Charge: An Important Molecular Property for Predicting High Concentration Behavior."
wn.com/Bioprocess International 2014 Interview Sumit Goswami, Pfizer
An interview with Sumit Goswami, Ph.D., Senior Scientist, Biotherapeutics, Pharmaceutical R&D; at Pfizer, from IBC Life Sciences' 2014 BioProcess International Conference & Exhibition in Boston, MA. At the conference, Dr. Goswami presented a case study on "Measurement of Charge: An Important Molecular Property for Predicting High Concentration Behavior."
- published: 12 Jun 2015
- views: 127
BioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life Sciences
- Order: Reorder
- Duration: 7:56
- Updated: 23 Jan 2015
- views: 93
In this interview, Guenter Jagschies discusses manufacturing facilities, how to access facilities where your biologics can be produced, adjusting facilities to ...
In this interview, Guenter Jagschies discusses manufacturing facilities, how to access facilities where your biologics can be produced, adjusting facilities to be efficient years after they are built, and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
wn.com/Bioprocess International 2014 Interview Guenter Jagschies, Ge Healthcare Life Sciences
In this interview, Guenter Jagschies discusses manufacturing facilities, how to access facilities where your biologics can be produced, adjusting facilities to be efficient years after they are built, and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 93
BioProcess International 2014 Interview: Ralph Lambalot, Abbvie
- Order: Reorder
- Duration: 5:38
- Updated: 23 Jan 2015
- views: 121
In this interview, Ralph Lambalot of Abbvie looks at the drivers and barriers to innovation in the bioprocessing industry. He sees disruptions in the industry ...
In this interview, Ralph Lambalot of Abbvie looks at the drivers and barriers to innovation in the bioprocessing industry. He sees disruptions in the industry coming in the form of biosimilars, molecule characterization, and changes within manufacturing technologies and how disposable manufacturing is changing their approach to developing molecules.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
wn.com/Bioprocess International 2014 Interview Ralph Lambalot, Abbvie
In this interview, Ralph Lambalot of Abbvie looks at the drivers and barriers to innovation in the bioprocessing industry. He sees disruptions in the industry coming in the form of biosimilars, molecule characterization, and changes within manufacturing technologies and how disposable manufacturing is changing their approach to developing molecules.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 121
BioProcess International 2014 Interview: David Kolwick, Amgen
- Order: Reorder
- Duration: 5:31
- Updated: 23 Jan 2015
- views: 41
In this interview with David Kolwick, he looks at the future of supply chains for bioprocessing, data collaboration possibilities for suppliers, globalization o...
In this interview with David Kolwick, he looks at the future of supply chains for bioprocessing, data collaboration possibilities for suppliers, globalization of the pharmaceutical supply chain and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
wn.com/Bioprocess International 2014 Interview David Kolwick, Amgen
In this interview with David Kolwick, he looks at the future of supply chains for bioprocessing, data collaboration possibilities for suppliers, globalization of the pharmaceutical supply chain and more.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 41
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; Center
- Order: Reorder
- Duration: 3:59
- Updated: 23 Jan 2015
- views: 85
In this interview, Bob Mattaliano discusses patient experiences and how pressure of the healthcare system influences drug development. He emphasizes the patien...
In this interview, Bob Mattaliano discusses patient experiences and how pressure of the healthcare system influences drug development. He emphasizes the patient experience. He also discusses the challenge of attracting and keeping the great minds of biopharma.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
wn.com/Bioprocess International 2014 Interview Bob Mattaliano, Sanofi Genzyme R D Center
In this interview, Bob Mattaliano discusses patient experiences and how pressure of the healthcare system influences drug development. He emphasizes the patient experience. He also discusses the challenge of attracting and keeping the great minds of biopharma.
For more information on BioProcess International, visit the webpage: http://bit.ly/1aaprGe
- published: 23 Jan 2015
- views: 85
Biogen Idec Care Deeply Day 2014
- Order: Reorder
- Duration: 2:34
- Updated: 03 Oct 2014
- views: 1665
This September Biogen Idec held it's 4th Annual Care Deeply Day, where employees volunteer across the globe in their local communities.
The Biogen Idec Care ...
This September Biogen Idec held it's 4th Annual Care Deeply Day, where employees volunteer across the globe in their local communities.
The Biogen Idec Care Deeply Volunteer Day is part of the company’s philanthropic focus on patients, science education and supporting local community needs.
This was our largest Care Deeply Day ever with over 2900 employees participating in over 140 Projects, volunteering over 14,500 hours in 27 countries. #CareDeeplyDay
wn.com/Biogen Idec Care Deeply Day 2014
This September Biogen Idec held it's 4th Annual Care Deeply Day, where employees volunteer across the globe in their local communities.
The Biogen Idec Care Deeply Volunteer Day is part of the company’s philanthropic focus on patients, science education and supporting local community needs.
This was our largest Care Deeply Day ever with over 2900 employees participating in over 140 Projects, volunteering over 14,500 hours in 27 countries. #CareDeeplyDay
- published: 03 Oct 2014
- views: 1665
SaharaTV interview with John Cox on September 8th, 2012.
- Order: Reorder
- Duration: 10:48
- Updated: 11 Sep 2012
- views: 70
- published: 11 Sep 2012
- views: 70
News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)
- Order: Reorder
- Duration: 1:48
- Updated: 08 Jun 2010
- views: 1040
Global biotechnology firm Biogen Idec Inc. (NASDAQ:BIIB) announced management changes Tuesday morning, including the retirement of its president, CEO and direct...
Global biotechnology firm Biogen Idec Inc. (NASDAQ:BIIB) announced management changes Tuesday morning, including the retirement of its president, CEO and director, James C. Mullen, who will retire from his position on June 8th.
The company's board of directors said they are in the final stages of picking a new CEO and will announce the new team member in the weeks ahead.
During the interim period, Biogen Idec's senior leadership will report to chairman of the board William D. Young.
"The Board has conducted a thorough selection process and is unified in its view that we will have the right leader with the right experience in place very soon to take Biogen Idec to the next level," said Young. "We expect to announce the appointment shortly."
Chief operating officer Robert A. Hamm will also retire on December 31st of this year, after 16 years with the company.
John G. Cox has been promoted to executive vice president of pharmaceutical operations and technology, and will oversee global manufacturing, technical development, supply chain, and more, for the company.
"On behalf of the board, I would like to reiterate our deepest thanks to Jim Mullen and Bob Hamm for their many years of leadership and contributions to the growth of Biogen Idec into a global biotechnology leader," said Young. "We wish them well in the future. We are pleased that John Cox has joined our talented senior leadership team."
Shares of Biogen Idec are trading down 0.92% Tuesday morning at $47.20.
wn.com/News Update Biogen Idec Inc. Ceo Coo To Retire, Company Announces Changes In Management (Biib)
Global biotechnology firm Biogen Idec Inc. (NASDAQ:BIIB) announced management changes Tuesday morning, including the retirement of its president, CEO and director, James C. Mullen, who will retire from his position on June 8th.
The company's board of directors said they are in the final stages of picking a new CEO and will announce the new team member in the weeks ahead.
During the interim period, Biogen Idec's senior leadership will report to chairman of the board William D. Young.
"The Board has conducted a thorough selection process and is unified in its view that we will have the right leader with the right experience in place very soon to take Biogen Idec to the next level," said Young. "We expect to announce the appointment shortly."
Chief operating officer Robert A. Hamm will also retire on December 31st of this year, after 16 years with the company.
John G. Cox has been promoted to executive vice president of pharmaceutical operations and technology, and will oversee global manufacturing, technical development, supply chain, and more, for the company.
"On behalf of the board, I would like to reiterate our deepest thanks to Jim Mullen and Bob Hamm for their many years of leadership and contributions to the growth of Biogen Idec into a global biotechnology leader," said Young. "We wish them well in the future. We are pleased that John Cox has joined our talented senior leadership team."
Shares of Biogen Idec are trading down 0.92% Tuesday morning at $47.20.
- published: 08 Jun 2010
- views: 1040
-
Behavior Based Interviewing / BioForum
Panelist: Greg Smith, Curriculum Coordinator for BioNetwork Bioprocessing Center The biopharmaceutical industry searches for the very best workforce to meet their goals and objectives. Graduates from biotechnology or bioprocessing programs have spent their time and money working hard to obtain the skill sets that are required to obtain these jobs, but many times are ill-prepared for the extensive interviews that are part of this industries "weeding-out" process. Behavior based interviews are a very commonly used screening tool that companies use to find out the applicants skill sets, their decision making capabilities, the applicants personalities, their work ethic, and just how well they will adapt to the openings that are advertised.This webinar will let job applicants know what ... -
Paula Cobb | Solutions at Work LIVE: Boston Syposium
After experiencing a major overhaul surrounding diversity and inclusion at her organization, Paula Cobb, Senior Vice President of MS Franchise Strategy at Biogen IDEC, speaks to the evolving and dynamic needs of people across all groups. She offers a senior business line owner's perspective on the positive impacts of creating a supportive and inclusive environment for all employees. -
#123: Technology and Strategy in Biotech, with Andi Karaboutis, Executive Vice President, Biogen
Technology plays a foundational role in biotech and the pharmaceutical industry. In this episode, we discuss the intersection of technology and strategy with one of the industry's leading executives, who also happens to be a woman. Andi Karaboutis is Executive Vice President Technology & Business Solutions at Biogen, located in Cambridge, MA. She is accountable for technologies that provide insights for drug discovery and patient benefit. For more information, go to https://www.cxotalk.com/technology-strategy-biotech-andi-karaboutis-executive-vice-president-biogen -
Business Strategy Manufacturing Flexibility and Versatility
Achieving manufacturing flexibility and versatility while considering real-life examples with industry expert, Sébastien Ribault, PhD, Director Provantage Biodevelopment/End to End Delivery Process Solution, Merck Millipore Hosted by Russ Somma, PhD, SommaTech Consulting
Behavior Based Interviewing / BioForum
- Order: Reorder
- Duration: 56:51
- Updated: 18 Apr 2012
- views: 2046
Panelist: Greg Smith, Curriculum Coordinator for BioNetwork Bioprocessing Center
The biopharmaceutical industry searches for the very best workforce to meet...
Panelist: Greg Smith, Curriculum Coordinator for BioNetwork Bioprocessing Center
The biopharmaceutical industry searches for the very best workforce to meet their goals and objectives. Graduates from biotechnology or bioprocessing programs have spent their time and money working hard to obtain the skill sets that are required to obtain these jobs, but many times are ill-prepared for the extensive interviews that are part of this industries "weeding-out" process.
Behavior based interviews are a very commonly used screening tool that companies use to find out the applicants skill sets, their decision making capabilities, the applicants personalities, their work ethic, and just how well they will adapt to the openings that are advertised.This webinar will let job applicants know what these interviews are so they are and what they can expect so they are not surprised when they experience them.
wn.com/Behavior Based Interviewing Bioforum
Panelist: Greg Smith, Curriculum Coordinator for BioNetwork Bioprocessing Center
The biopharmaceutical industry searches for the very best workforce to meet their goals and objectives. Graduates from biotechnology or bioprocessing programs have spent their time and money working hard to obtain the skill sets that are required to obtain these jobs, but many times are ill-prepared for the extensive interviews that are part of this industries "weeding-out" process.
Behavior based interviews are a very commonly used screening tool that companies use to find out the applicants skill sets, their decision making capabilities, the applicants personalities, their work ethic, and just how well they will adapt to the openings that are advertised.This webinar will let job applicants know what these interviews are so they are and what they can expect so they are not surprised when they experience them.
- published: 18 Apr 2012
- views: 2046
Paula Cobb | Solutions at Work LIVE: Boston Syposium
- Order: Reorder
- Duration: 21:32
- Updated: 25 Sep 2014
- views: 205
After experiencing a major overhaul surrounding diversity and inclusion at her organization, Paula Cobb, Senior Vice President of MS Franchise Strategy at Bioge...
After experiencing a major overhaul surrounding diversity and inclusion at her organization, Paula Cobb, Senior Vice President of MS Franchise Strategy at Biogen IDEC, speaks to the evolving and dynamic needs of people across all groups. She offers a senior business line owner's perspective on the positive impacts of creating a supportive and inclusive environment for all employees.
wn.com/Paula Cobb | Solutions At Work Live Boston Syposium
After experiencing a major overhaul surrounding diversity and inclusion at her organization, Paula Cobb, Senior Vice President of MS Franchise Strategy at Biogen IDEC, speaks to the evolving and dynamic needs of people across all groups. She offers a senior business line owner's perspective on the positive impacts of creating a supportive and inclusive environment for all employees.
- published: 25 Sep 2014
- views: 205
#123: Technology and Strategy in Biotech, with Andi Karaboutis, Executive Vice President, Biogen
- Order: Reorder
- Duration: 46:27
- Updated: 31 Jul 2015
- views: 673
Technology plays a foundational role in biotech and the pharmaceutical industry. In this episode, we discuss the intersection of technology and strategy with on...
Technology plays a foundational role in biotech and the pharmaceutical industry. In this episode, we discuss the intersection of technology and strategy with one of the industry's leading executives, who also happens to be a woman.
Andi Karaboutis is Executive Vice President Technology & Business Solutions at Biogen, located in Cambridge, MA. She is accountable for technologies that provide insights for drug discovery and patient benefit.
For more information, go to https://www.cxotalk.com/technology-strategy-biotech-andi-karaboutis-executive-vice-president-biogen
wn.com/123 Technology And Strategy In Biotech, With Andi Karaboutis, Executive Vice President, Biogen
Technology plays a foundational role in biotech and the pharmaceutical industry. In this episode, we discuss the intersection of technology and strategy with one of the industry's leading executives, who also happens to be a woman.
Andi Karaboutis is Executive Vice President Technology & Business Solutions at Biogen, located in Cambridge, MA. She is accountable for technologies that provide insights for drug discovery and patient benefit.
For more information, go to https://www.cxotalk.com/technology-strategy-biotech-andi-karaboutis-executive-vice-president-biogen
- published: 31 Jul 2015
- views: 673
Business Strategy Manufacturing Flexibility and Versatility
- Order: Reorder
- Duration: 26:00
- Updated: 20 May 2015
- views: 156
Achieving manufacturing flexibility and versatility while considering real-life examples with industry expert, Sébastien Ribault, PhD, Director Provantage Biode...
Achieving manufacturing flexibility and versatility while considering real-life examples with industry expert, Sébastien Ribault, PhD, Director Provantage Biodevelopment/End to End Delivery Process Solution, Merck Millipore
Hosted by Russ Somma, PhD, SommaTech Consulting
wn.com/Business Strategy Manufacturing Flexibility And Versatility
Achieving manufacturing flexibility and versatility while considering real-life examples with industry expert, Sébastien Ribault, PhD, Director Provantage Biodevelopment/End to End Delivery Process Solution, Merck Millipore
Hosted by Russ Somma, PhD, SommaTech Consulting
- published: 20 May 2015
- views: 156
back
- Playlist
- Chat
back
- Playlist
- Chat
4:53
BioProcess International 2014 Interview: John Cox, Biogen Idec
In this interview, John Cox of Biogen Idec discusses the changes in bioprocessing over the...
published: 23 Jan 2015
BioProcess International 2014 Interview: John Cox, Biogen Idec
BioProcess International 2014 Interview: John Cox, Biogen Idec
- Report rights infringement
- published: 23 Jan 2015
- views: 228
5:43
BioProcess International 2014 Interview: Jonathan Romero, Biogen Idec
In this interview, Jonathan Romero of Biogen Idec looks at the lifecycle management of pro...
published: 23 Jan 2015
BioProcess International 2014 Interview: Jonathan Romero, Biogen Idec
BioProcess International 2014 Interview: Jonathan Romero, Biogen Idec
- Report rights infringement
- published: 23 Jan 2015
- views: 114
6:49
BioProcess International 2014 Interview: Sumit Goswami, Pfizer
An interview with Sumit Goswami, Ph.D., Senior Scientist, Biotherapeutics, Pharmaceutical ...
published: 12 Jun 2015
BioProcess International 2014 Interview: Sumit Goswami, Pfizer
BioProcess International 2014 Interview: Sumit Goswami, Pfizer
- Report rights infringement
- published: 12 Jun 2015
- views: 127
7:56
BioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life Sciences
In this interview, Guenter Jagschies discusses manufacturing facilities, how to access fac...
published: 23 Jan 2015
BioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life Sciences
BioProcess International 2014 Interview: Guenter Jagschies, GE Healthcare Life Sciences
- Report rights infringement
- published: 23 Jan 2015
- views: 93
5:38
BioProcess International 2014 Interview: Ralph Lambalot, Abbvie
In this interview, Ralph Lambalot of Abbvie looks at the drivers and barriers to innovatio...
published: 23 Jan 2015
BioProcess International 2014 Interview: Ralph Lambalot, Abbvie
BioProcess International 2014 Interview: Ralph Lambalot, Abbvie
- Report rights infringement
- published: 23 Jan 2015
- views: 121
5:31
BioProcess International 2014 Interview: David Kolwick, Amgen
In this interview with David Kolwick, he looks at the future of supply chains for bioproce...
published: 23 Jan 2015
BioProcess International 2014 Interview: David Kolwick, Amgen
BioProcess International 2014 Interview: David Kolwick, Amgen
- Report rights infringement
- published: 23 Jan 2015
- views: 41
3:59
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; Center
In this interview, Bob Mattaliano discusses patient experiences and how pressure of the he...
published: 23 Jan 2015
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; Center
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D; Center
- Report rights infringement
- published: 23 Jan 2015
- views: 85
2:34
Biogen Idec Care Deeply Day 2014
This September Biogen Idec held it's 4th Annual Care Deeply Day, where employees volunteer...
published: 03 Oct 2014
Biogen Idec Care Deeply Day 2014
Biogen Idec Care Deeply Day 2014
- Report rights infringement
- published: 03 Oct 2014
- views: 1665
10:48
SaharaTV interview with John Cox on September 8th, 2012.
published: 11 Sep 2012
SaharaTV interview with John Cox on September 8th, 2012.
SaharaTV interview with John Cox on September 8th, 2012.
- Report rights infringement
- published: 11 Sep 2012
- views: 70
1:48
News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)
Global biotechnology firm Biogen Idec Inc. (NASDAQ:BIIB) announced management changes Tues...
published: 08 Jun 2010
News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)
News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)
- Report rights infringement
- published: 08 Jun 2010
- views: 1040
back
- Playlist
- Chat
56:51
Behavior Based Interviewing / BioForum
Panelist: Greg Smith, Curriculum Coordinator for BioNetwork Bioprocessing Center
The b...
published: 18 Apr 2012
Behavior Based Interviewing / BioForum
Behavior Based Interviewing / BioForum
- Report rights infringement
- published: 18 Apr 2012
- views: 2046
21:32
Paula Cobb | Solutions at Work LIVE: Boston Syposium
After experiencing a major overhaul surrounding diversity and inclusion at her organizatio...
published: 25 Sep 2014
Paula Cobb | Solutions at Work LIVE: Boston Syposium
Paula Cobb | Solutions at Work LIVE: Boston Syposium
- Report rights infringement
- published: 25 Sep 2014
- views: 205
46:27
#123: Technology and Strategy in Biotech, with Andi Karaboutis, Executive Vice President, Biogen
Technology plays a foundational role in biotech and the pharmaceutical industry. In this e...
published: 31 Jul 2015
#123: Technology and Strategy in Biotech, with Andi Karaboutis, Executive Vice President, Biogen
#123: Technology and Strategy in Biotech, with Andi Karaboutis, Executive Vice President, Biogen
- Report rights infringement
- published: 31 Jul 2015
- views: 673
26:00
Business Strategy Manufacturing Flexibility and Versatility
Achieving manufacturing flexibility and versatility while considering real-life examples w...
published: 20 May 2015
Business Strategy Manufacturing Flexibility and Versatility
Business Strategy Manufacturing Flexibility and Versatility
- Report rights infringement
- published: 20 May 2015
- views: 156
Behavior Based Interviewing / BioForum...
Paula Cobb | Solutions at Work LIVE: Boston Syposi...
#123: Technology and Strategy in Biotech, with And...
Business Strategy Manufacturing Flexibility and Ve...
photo: AP / James MacPherson, FILE
Arrest Warrants Issued For Jill Stein And First Nation Sisters, Where’s Hillary?
Edit WorldNews.com 12 Sep 2016
Article by WN.com Correspondent Dallas Darling For Hillary Clinton, her oft quoted “Human’s rights are women’s rights and women’s rights are human rights” evidently doesn’t include Jill Stein and First Nation sisters ... delegate to the U.N ... 52 Weekly Reflections On Modern-Day Imperialism, Militarism, And Consumerism in the Context of John’s Apocalyptic Vision, and The Other Side Of Christianity....
photo: ESA/Hubble & NASA
We Are All Floating Lost In A Directionless Universe, So Give Up Now
Edit Huffington Post 12 Sep 2016
In case you were clinging to any hope that the earth isn’t just spinning around in a vast and directionless universe, let us shatter that illusion for you. Scientists have confirmed that we are officially lost in a universe that has no up or down, and no axis to rotate around. . Oh good. The long-standing debate about the way in which the universe is expanding focuses on two possibilities. ... SEE ALSO ... . . > ....
photo: AP / Chris Pizzello, File
Transgender actress Alexis Arquette has died at 47
Edit Lexington Herald-Leader 12 Sep 2016
Alexis Arquette, the transgender character actress and sibling of actors David, Rosanna, Richmond and Patricia Arquette, died early Sunday morning in Los Angeles ... “We learned what real bravery is through watching her journey of living as a trans woman ... “They asked me if I wanted to read for a role because they knew that I’d done a drag thing at one of my friend’s clubs,” Arquette said in a 1999 Index Magazine interview....
photo: NASA / CXC/M.Weiss
[VIDEO]: New Data Adds To Understanding Black Holes
Edit WorldNews.com 12 Sep 2016
Information gleaned from a short-lived Japanese satellite has given scientists worldwide vital new information on black holes and supernovas, VOA News reported Monday.In February, Japan’s space agency launched its Astro-H satellite into orbit to examine large-scale structures in the cosmos, the report said. This study included examination of supermassive black holes that exist at the center of most galaxies ... ....
photo: AP / Andrew Harnik
Pneumonia brings Hillary Clinton's health back as hot issue
Edit The Roanoke Times 12 Sep 2016
The Democratic presidential nominee "felt overheated" Sunday and left the ground zero ceremony after about 90 minutes, her campaign said. A video of her departure shows Clinton appearing to stumble as three staff members hold her up and help her into a van ... In 2008, Republican nominee John McCain made public more than a thousand pages of his medical history to show he was cancer-free and fit to serve as president at age 71 ... Dr ... ___ ... ___....
« back to news headlines
Johns Hopkins SAIS to host 7th Global Conference on Women in the Boardroom on Sept. 7, 2016 (Johns Hopkins SAIS)
Edit Public Technologies 12 Sep 2016
Johns Hopkins SAIS) ... The 7th SAIS Global Conference on Women in the Boardroom will be held on Wednesday, September 7, 2016 at the Johns Hopkins University Paul H. Nitze School of Advanced International Studies (SAIS) ... The conference will include speeches, interviews, and panel discussions featuring. ... Johns Hopkins SAIS ... Members of the working press should send RSVPs and requests to interview conference participants to sande100@jhu.edu....
Customer Engagement (Southern Methodist University)
Edit Public Technologies 12 Sep 2016
Dallas, TX (SMU) - The nation's first academic institute devoted to the study of customer engagement will be based at SMU in the University's Cox School of Business thanks to a $10 million gift from Diane and Harold (Hal) Brierley ... 'It is an honor for SMU and the Cox School of Business to serve as home of the Brierley Institute for Customer Engagement,' said SMU President R ... About SMU Cox ... Cox in 1978....
OCB Falls 2-1 to TFC II (Orlando City Soccer Club)
Edit Public Technologies 12 Sep 2016
Michael Cox scored his team-leading 11th goal of the season and Pedro Ribeiro earned his first minutes since recovering from injury ... The Lions struck quickly in the fifth minute when Zach Hayden was able to hit Cox from a throw-in on the left side. Cox let the ball roll past him, turned and split two defenders in a darting run towards goal ... OCB - Michael Cox (Zach Hayden) 5' ... TFC- Ricardo John (Raheem Edwards) 71'....
Young Reds win OSC Finale (Toronto FC)
Edit Public Technologies 12 Sep 2016
Shaan Hundal and Ricardo John would both find the back of the Lions net to lead the Reds to victory. Toronto FC II did not get off to the start they wanted as Canadian forward Michael Cox was able to get some space in the box and fire his shot off the post and past keeper Quillan Roberts ... Second half substitute Raheem Edwards sent a cross from inside the box for Ricardo John who headed home his third of the season ... OCB - Michael Cox 5'....
JonBenet Ramsey series questions key DNA evidence
Edit New York Post 12 Sep 2016
, that includes an interview with John Mark Karr, the only person ever arrested for the murder (he was never charged for lack of evidence) ... In addition to Coombes’ commentary, the ID series also features interviews with Bobby Brown and Steve Pease, both former Colorado Springs Detectives; Ramsey family private investigators Ollie Gray and John San ......
Budget to be discussed at FG meeting in Kildare
Edit RTE 12 Sep 2016
Both reports will point to internal communication deficiencies. The reviews will not be published today as it is understood they will be subject to further internal deliberation....
Some Paralympic athletes are competing in multiple sports
Edit Richmond Times Dispatch 12 Sep 2016
So she took up Nordic skiing, qualified for the 2014 U.S ... Nine athletes are competing in more than one sport at the Rio Games, according to the International Paralympic Committee, and dozens of others are competing in a different sport than they did at previous Paralympics ... British track and field sprinter Kadeena Cox took up road cycling about 18 months ago and decided she would compete in both sports rather than choosing one....
Thieves stole taxpayer data from IRS ‘Get Transcript’ service
Edit The Washington Post 12 Sep 2016
Shortly after the Internal Revenue Service launched its “Get Transcript” service in 2014, IRS Commissioner John Koskinen lauded it as “another innovation…a secure online system that allows taxpayers to view and print a record of their IRS account, also known as a transcript, in a matter of minutes.” Unfortunately, it wasn’t just taxpayers who got their []> ... ....
The Social Festival 2016 review
Edit Skiddle 12 Sep 2016
Carl Cox, Solomun, High Contrast, Loco Dice, Eats Everything, John Digweed, Sasha, Goldie, Roni Size, Andrew Weatherall, George Fitzgerald, LTJ Bukem, DJ ZINC, Laurent Garnier, Nic Fanciulli, Dubfire, Guy Gerber, ICICLE, Paul Kalkbrenner, Jon RundellHotels ... John Digweed. Carl Cox - Music Is Revolution The Final Chapter 13th Sep. Carl Cox. Carl Cox - Music Is Revolution The Final Chapter 13th Sep....
Clinton's former CIA director, Jim Woolsey, joins Trump campaign as senior advisor
Edit AOL 12 Sep 2016
Treasury secretary, gestures as he speaks during a Bloomberg Television interview in London, U.K., on Monday, May 11, 2015 ... Former National Security Adviser Brent Scowcroft listens during a forum discussion at the Johns Hopkins University School of Advanced International Studies on October 22, 2013 in Washington ... John McCain on his 2008 campaign for president....
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
Edit Nasdaq Globe Newswire 12 Sep 2016
NEWTON, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq.KPTI), a clinical-stage pharmaceutical company, today announced the appointment of Humphrey A.R ... Dr ... “Dr ... Shacham. “I am pleased to welcome Dr ... Gardner ... Before joining AstraZeneca in 2011, he served as Senior Director and Global Head of Oncology Translational Laboratories at Novartis, and as Associate Director and Head of Research Pathology at Biogen Idec....
AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June ...
Edit Stockhouse 12 Sep 2016
AGTC is currently enrolling patients in a Phase 1/2 clinical trial for XLRS, a program on which the company is collaborating with Biogen ... Vendor errors required the company to re-test the study agent for a process component. Upon re-testing, the study agent met all specifications and the company now has several backup vendors as well as internal testing capabilities....
- 1
- 2
- 3
- 4
- 5
- Next page »
